{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:32:33Z","timestamp":1788280353505,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ncl.2020.09.011","type":"journal-article","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T22:12:19Z","timestamp":1604700739000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Treatment of Viral Encephalitis"],"prefix":"10.1016","volume":"39","author":[{"suffix":"Jr.","given":"Allen J.","family":"Aksamit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ncl.2020.09.011_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1212\/WNL.0000000000000086","article-title":"Burden of encephalitis-associated hospitalizations in the United States, 1998-2010","volume":"82","author":"Vora","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2020.09.011_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0000000000001190","article-title":"The spectrum of acute encephalitis: causes, management, and predictors of outcome","volume":"84","author":"Singh","year":"2015","journal-title":"Neurology"},{"issue":"16","key":"10.1016\/j.ncl.2020.09.011_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMc1602964","article-title":"Zika virus associated with meningoencephalitis","volume":"374","author":"Carteaux","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ncl.2020.09.011_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.0000000000002234","article-title":"Chikungunya virus-associated encephalitis: a cohort study on La Reunion Island, 2005-2009","volume":"86","author":"Gerardin","year":"2016","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2020.09.011_bib5","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1128\/JCM.00730-16","article-title":"Multicenter evaluation of BioFire FilmArray meningitis\/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens","volume":"54","author":"Leber","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.ncl.2020.09.011_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/imj.12749","article-title":"Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand","volume":"45","author":"Britton","year":"2015","journal-title":"Intern Med J"},{"issue":"8","key":"10.1016\/j.ncl.2020.09.011_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/j.1468-1331.2010.02970.x","article-title":"Viral meningoencephalitis: a review of diagnostic methods and guidelines for management","volume":"17","author":"Steiner","year":"2010","journal-title":"Eur J Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2020.09.011_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ncl.2020.09.011_bib9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/589747","article-title":"The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"47","author":"Tunkel","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ncl.2020.09.011_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.spid.2004.09.007","article-title":"Herpes simplex encephalitis: children and adolescents","volume":"16","author":"Whitley","year":"2005","journal-title":"Semin Pediatr Infect Dis"},{"issue":"9","key":"10.1016\/j.ncl.2020.09.011_bib11","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/cid\/civ051","article-title":"Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics","volume":"60","author":"Chow","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"8405","key":"10.1016\/j.ncl.2020.09.011_bib12","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(84)92623-0","article-title":"Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients","volume":"2","author":"Skoldenberg","year":"1984","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ncl.2020.09.011_bib13","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1056\/NEJM198601163140303","article-title":"Vidarabine versus acyclovir therapy in herpes simplex encephalitis","volume":"314","author":"Whitley","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ncl.2020.09.011_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ369","article-title":"Herpes simplex encephalitis: lack of clinical benefit of long-term valacyclovir therapy","volume":"61","author":"Gnann","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ncl.2020.09.011_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2377-8-40","article-title":"Protocol for German trial of Acyclovir and corticosteroids in Herpes-simplex-virus-encephalitis (GACHE): a multicenter, multinational, randomized, double-blind, placebo-controlled German, Austrian and Dutch trial [ISRCTN45122933]","volume":"8","author":"Martinez-Torres","year":"2008","journal-title":"BMC Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2020.09.011_bib16","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jnnp.2007.129098","article-title":"Viral encephalitis: a clinician's guide","volume":"7","author":"Solomon","year":"2007","journal-title":"Pract Neurol"},{"key":"10.1016\/j.ncl.2020.09.011_bib17","series-title":"Dexamethasone in herpes simplex virus encephalitis open label randomized controlled trial with an observer-blinded evaluation at 6\u00a0months","author":"Stahl","year":"2017"},{"issue":"2","key":"10.1016\/j.ncl.2020.09.011_bib18","first-page":"163","article-title":"Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults","volume":"253","author":"Skoldenberg","year":"2006","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2020.09.011_bib19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/01.WNL.0000073985.71759.7C","article-title":"Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities","volume":"61","author":"De Tiege","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2020.09.011_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24083","article-title":"Herpes simplex virus encephalitis is a trigger of brain autoimmunity","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann Neurol"},{"issue":"18","key":"10.1016\/j.ncl.2020.09.011_bib21","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1212\/WNL.0b013e3182a9f531","article-title":"Herpes simplex virus-1 encephalitis can trigger anti-NMDA receptor encephalitis: case report","volume":"81","author":"Leypoldt","year":"2013","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2020.09.011_bib22","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2020.09.011_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1469-0691.2011.03705.x","article-title":"Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients","volume":"18","author":"De Broucker","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.ncl.2020.09.011_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00002030-200003310-00007","article-title":"Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients","volume":"14","author":"Anduze-Faris","year":"2000","journal-title":"AIDS"},{"issue":"16","key":"10.1016\/j.ncl.2020.09.011_bib25","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1212\/WNL.0b013e31828cf8a2","article-title":"Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation","volume":"80","author":"Bhanushali","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2020.09.011_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1212\/01.wnl.0000195890.70898.1f","article-title":"CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis","volume":"66","author":"Tyler","year":"2006","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2020.09.011_bib27","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/427945","article-title":"Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases","volume":"40","author":"Kalil","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"11\u201312","key":"10.1016\/j.ncl.2020.09.011_bib28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1080\/00365540500262690","article-title":"Failure of interferon alpha-2b in a patient with West Nile virus meningoencephalitis and acute flaccid paralysis","volume":"37","author":"Chan-Tack","year":"2005","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.ncl.2020.09.011_bib29","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1086\/500216","article-title":"Persistent neuroinvasive West Nile virus infection in an immunocompromised patient","volume":"42","author":"Penn","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.ncl.2020.09.011_bib30","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3201\/eid2511.190537","article-title":"Lack of Efficacy of High-Titered Immunoglobulin in Patients with West Nile Virus Central Nervous System Disease","volume":"25","author":"Gnann","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.ncl.2020.09.011_bib31","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1128\/AAC.00069-07","article-title":"In\u00a0vitro resistance selection and in\u00a0vivo efficacy of morpholino oligomers against West Nile virus","volume":"51","author":"Deas","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ncl.2020.09.011_bib32","series-title":"Eastern equine encephalitis","year":"2019"},{"issue":"1","key":"10.1016\/j.ncl.2020.09.011_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/1941874415578533","article-title":"Eastern equine encephalitis treated with intravenous immunoglobulins","volume":"6","author":"Mukerji","year":"2016","journal-title":"Neurohospitalist"},{"issue":"1","key":"10.1016\/j.ncl.2020.09.011_bib34","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12028-013-9822-5","article-title":"Successful management of severe neuroinvasive eastern equine encephalitis","volume":"19","author":"Wendell","year":"2013","journal-title":"Neurocrit Care"},{"issue":"4","key":"10.1016\/j.ncl.2020.09.011_bib35","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ncl.2018.06.002","article-title":"Progressive multifocal leukoencephalopathy","volume":"36","author":"Grebenciucova","year":"2018","journal-title":"Neurol Clin"},{"issue":"4","key":"10.1016\/j.ncl.2020.09.011_bib36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"issue":"12","key":"10.1016\/j.ncl.2020.09.011_bib37","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1212\/WNL.0000000000003740","article-title":"No evidence of beneficial effects of plasmapheresis in natalizumab-associated PML","volume":"88","author":"Landi","year":"2017","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.ncl.2020.09.011_bib38","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1815039","article-title":"Pembrolizumab treatment for progressive multifocal leukoencephalopathy","volume":"380","author":"Cortese","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ncl.2020.09.011_bib39","doi-asserted-by":"crossref","first-page":"e628","DOI":"10.1212\/NXI.0000000000000628","article-title":"Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency","volume":"6","author":"Kupper","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.ncl.2020.09.011_bib40","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1212\/NXI.0000000000000627","article-title":"Ineffective treatment of PML with pembrolizumab: Exhausted memory T-cell subsets as a clue?","volume":"6","author":"Pawlitzki","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"10.1016\/j.ncl.2020.09.011_bib41","doi-asserted-by":"crossref","first-page":"e629","DOI":"10.1212\/NXI.0000000000000629","article-title":"Pembrolizumab as a treatment for PML? Waiting for Godot","volume":"6","author":"Du Pasquier","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"15","key":"10.1016\/j.ncl.2020.09.011_bib42","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMoa1801540","article-title":"Allogeneic BK virus-specific T\u00a0cells for progressive multifocal leukoencephalopathy","volume":"379","author":"Muftuoglu","year":"2018","journal-title":"N\u00a0Engl J Med"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861920300785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:20:03Z","timestamp":1760005203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861920300785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0733861920300785"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2020.09.011","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Viral Encephalitis","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2020.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}